Healthier life
better world

Medifron DBT, Inc. is a clinical stage biopharmaceutical company focusing on the development of Alzheimer's disease (AD) and neuropathic pain (NP) treatment and AD diagnostics.

Since its establishment in 1999, we have been able to license the outcome of the development of new drugs to Big Pharma, including Grünenthal and Roche, and have jointly developed them. This is the evidence that Medifron's technology is recognized in the global market.

Business Strategy


Contact Us